Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Urology. 2017 Aug 4;109:67–73. doi: 10.1016/j.urology.2017.07.039

Table 1.

Demographics, UI, OAB & nocturia symptoms

OAB Controls p-value (adjusted for age and sex)
Demographics
No. of subjects 51 30
Age (mean ± SD) 53.8 ± 11.9 54.2 ± 12.3 0.984
Sex (% female) 72.5% 56.7% 0.143
Race (% white) 43.1% 63.3% 0.079
UI/OAB measures (over past 4 weeks) (mean ± SD)
ICIQ-UI (urinary incontinence, 0–21) 12.0 ± 4.9 1.4 ± 2.0 0.002
ICIQ-OAB (overactive bladder, 0–16) 9.3 ± 2.6 2.0 ± 1.5 0.007
OAB-q symptom bother (6–36) 18.7 ± 6.7 2.2 ± 2.8 <0.001
OAB-q quality of life (13–78) 30.2 ± 16.6 1.9 ± 2.9 0.003
UDI-6 (urogenital distress inventory, 0–24) 12.7 ± 5.6 0.9 ± 1.4 <0.001
IIQ-7 (incontinence impact questionnaire, 0–28) 8.8 ± 8.2 0.1 ± 0.4 0.002
Nocturia measures (over past 4 weeks)
Number of nighttime urinations (mean ± SD) 2.6 ± 1.1 0.9 ± 0.7 <0.001
% with nocturia (≥ 1) 94.0% 76.7% 0.023
Odds ratio of having nocturia (≥ 1) in OAB compared to controls OR = 6.87
95% CI [1.31,36.1]
0.023
% with nocturia (≥ 2) 86.0% 13.3% <0.001
Odds ratio of having nocturia (≥ 2) in OAB compared to controls OR = 41.9
95% CI [10.7, 164.8]
<0.001
% with nighttime urinary incontinence 13.7% 3.3% 0.247
Odds ratio of having nighttime UI in OAB compared to controls OR = 4.5
95% CI [0.5, 39.9]
0.173